From: The effect of hypocalcemia on motor symptoms of Parkinson’s disease
Clinical scales | PD cases N = 28 (93.33%) | t/X2 | p | |||
---|---|---|---|---|---|---|
Normocalcemia N = 12 (42.85%) | Hypocalcemia N = 16 (57.15%) | |||||
No | % | No | % | |||
Dominant symptoms | ||||||
Tremor dominant | 5 | 41.7% | 4 | 25.0% | 0.96 | 0.62 |
Akinetic/rigid | 3 | 25.0% | 6 | 37.5% | ||
Mixed | 4 | 33.3% | 6 | 37.5% | ||
Modified H–Y scale | ||||||
Stage 2 | 6 | 50.0% | 3 | 18.75% | 12.393 | 0.002 * |
Stage 2.5 | 5 | 41.6% | 10 | 62.5% | ||
Stage 3 | 1 | 8.31% | 3 | 18.75% | ||
Mean ± SD | 2.16 ± 0.24 | 2.59 ± 0.27 | − 3.402 | 0.001* | ||
UPDRS III (Motor) | ||||||
Mean ± SD | 25. 91 ± 5.46 | 32.54 ± 5.12 | − 3.223 | 0.001* | ||
UPDRS II (ADL) | ||||||
Mean ± SD | 25.75 ± 5.94 | 32.54 ± 5.12 | − 3.590* | 0.003* | ||
S–E ADLscale | ||||||
Mean ± SD | 80.0 ± 8.52 | 60.62 ± 8.56 | 5.402 | 0.001* |